Literature DB >> 20192710

Vaccination and healthy aging.

Stefania Maggi1.   

Abstract

The aging process in humans is associated with a decrease in immune function (immunosenescence) and an increase in comorbid disorders. When combined with environmental factors this can lead to an increased risk and severity of infectious diseases. Diseases in older adults (>/=70 years) tend to be more severe and have a greater impact on health outcomes such as morbidity, disability, quality of life and mortality. However, some of the more common infections such as influenza and pneumococcal infection are vaccine preventable, but the uptake of such preventive strategies in adults has been poor. In this review some of the key clinical findings supporting the benefits of adult immunization are highlighted. Vaccination of the adult population needs to be a key component of a healthy aging strategy, since there is already convincing evidence that this approach can have an important impact on morbidity, mortality and quality of life.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20192710     DOI: 10.1586/erv.10.26

Source DB:  PubMed          Journal:  Expert Rev Vaccines        ISSN: 1476-0584            Impact factor:   5.217


  6 in total

1.  The future of immunization policies in Italy and in the European Union: The Declaration of Erice.

Authors:  Anna Odone; Gaetano M Fara; Giuseppe Giammaco; Francesco Blangiardi; Carlo Signorelli
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

Review 2.  Impact of aging on viral infections.

Authors:  Jin Leng; Daniel R Goldstein
Journal:  Microbes Infect       Date:  2010-09-16       Impact factor: 2.700

Review 3.  Recommended immunization schedules for adults: Clinical practice guidelines by the Escmid Vaccine Study Group (EVASG), European Geriatric Medicine Society (EUGMS) and the World Association for Infectious Diseases and Immunological Disorders (WAidid).

Authors:  Susanna Esposito; Paolo Bonanni; Stefania Maggi; Litjan Tan; Filippo Ansaldi; Pier Luigi Lopalco; Ron Dagan; Jean-Pierre Michel; Pierre van Damme; Jacques Gaillat; Roman Prymula; Timo Vesikari; Cristina Mussini; Uwe Frank; Albert Osterhaus; Lucia Pastore Celentano; Marta Rossi; Valentina Guercio; Gaetan Gavazzi
Journal:  Hum Vaccin Immunother       Date:  2016-05-02       Impact factor: 3.452

Review 4.  Vaccination programs for older adults in an era of demographic change.

Authors:  T Mark Doherty; Mark P Connolly; Giuseppe Del Giudice; Johan Flamaing; Jorg J Goronzy; Beatrix Grubeck-Loebenstein; Paul-Henri Lambert; Stefania Maggi; Janet E McElhaney; Hideaki Nagai; William Schaffner; Ruprecht Schmidt-Ott; Edward Walsh; Alberta Di Pasquale
Journal:  Eur Geriatr Med       Date:  2018-03-19       Impact factor: 1.710

5.  An example of clinical inertia in geriatrics.

Authors:  Tahir Belice; Mustafa Ubay; Fatma O Gozubuyuk; Rasim S Yilmaz; Arif Yuksel
Journal:  J Family Med Prim Care       Date:  2020-11-30

Review 6.  Promising Expectations for Pneumococcal Vaccination during COVID-19.

Authors:  Hyobin Im; Jinhui Ser; Uk Sim; Hoonsung Cho
Journal:  Vaccines (Basel)       Date:  2021-12-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.